These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
146 related articles for article (PubMed ID: 37930068)
1. CMV antiviral stewardship in transplantation - the next frontier. Yong MK Curr Opin Infect Dis; 2023 Dec; 36(6):495-496. PubMed ID: 37930068 [No Abstract] [Full Text] [Related]
2. The next frontier: cytomegalovirus antiviral stewardship programs in solid organ transplant. Kleiboeker HL; Saddler CM; Jorgenson MR Curr Opin Infect Dis; 2023 Dec; 36(6):497-504. PubMed ID: 37815319 [TBL] [Abstract][Full Text] [Related]
3. Preemptive and prophylactic ganciclovir therapy for CMV infection in heart transplant patients. Paniagua MJ; Crespo-Leiro MG; Rodriguez JA; Fojón S; Zúñiga MC; Cañizares A; Rey R; Cuenca JJ; Juffé A; Castro-Beiras A Transplant Proc; 1999 Sep; 31(6):2528-9. PubMed ID: 10500701 [No Abstract] [Full Text] [Related]
4. Preemptive versus sequential prophylactic-preemptive treatment regimens for cytomegalovirus in renal transplantation: comparison of treatment failure and antiviral resistance. van der Beek MT; Berger SP; Vossen AC; van der Blij-de Brouwer CS; Press RR; de Fijter JW; Claas EC; Kroes AC Transplantation; 2010 Feb; 89(3):320-6. PubMed ID: 20145523 [TBL] [Abstract][Full Text] [Related]
5. Cytomegalovirus prophylaxis with ganciclovir and cytomegalovirus immune globulin in liver and intestinal transplantation. Tzakis AG Transpl Infect Dis; 2001; 3 Suppl 2():35-9. PubMed ID: 11926748 [TBL] [Abstract][Full Text] [Related]
6. Current status and impact of CMV prevention following pediatric organ transplantation. Allen UD Pediatr Transplant; 2008 Jun; 12(4):389-92. PubMed ID: 18466425 [No Abstract] [Full Text] [Related]
7. Cytomegalovirus pp65 antigenemia-guided early treatment with ganciclovir versus ganciclovir at engraftment after allogeneic marrow transplantation: a randomized double-blind study. Boeckh M; Gooley TA; Myerson D; Cunningham T; Schoch G; Bowden RA Blood; 1996 Nov; 88(10):4063-71. PubMed ID: 8916975 [TBL] [Abstract][Full Text] [Related]
8. Ganciclovir. An update of its use in the prevention of cytomegalovirus infection and disease in transplant recipients. Noble S; Faulds D Drugs; 1998 Jul; 56(1):115-46. PubMed ID: 9664203 [TBL] [Abstract][Full Text] [Related]
9. Prevention and management of cytomegalovirus infection in solid-organ transplantation. Mwintshi K; Brennan DC Expert Rev Anti Infect Ther; 2007 Apr; 5(2):295-304. PubMed ID: 17402844 [TBL] [Abstract][Full Text] [Related]
10. Current management strategies for the prevention and treatment of cytomegalovirus infection in pediatric transplant recipients. Bueno J; Ramil C; Green M Paediatr Drugs; 2002; 4(5):279-90. PubMed ID: 11994033 [TBL] [Abstract][Full Text] [Related]
12. Cytomegalovirus antiviral stewardship in solid organ transplant recipients: A new gold standard. Jorgenson MR; Descourouez JL; Kleiboeker H; Goldrosen K; Schulz L; Rice JP; Odorico JS; Mandelbrot DA; Smith JA; Saddler CM Transpl Infect Dis; 2022 Oct; 24(5):e13864. PubMed ID: 35603982 [TBL] [Abstract][Full Text] [Related]
13. [Cytomegalovirus detection in blood and bronchoalveolar lavage, and prophylaxis or preemptive treatment with ganciclovir in children with allogeneic stem cell transplantation]. Figueroa C; Bonduel M; Paganini H; Botto H; Casimir L Enferm Infecc Microbiol Clin; 2006 Mar; 24(3):162-6. PubMed ID: 16606557 [TBL] [Abstract][Full Text] [Related]
14. Ganciclovir susceptibilities and analysis of UL97 region in cytomegalovirus (CMV) isolates from bone marrow recipients with CMV disease after antiviral prophylaxis. Erice A; Borrell N; Li W; Miller WJ; Balfour HH J Infect Dis; 1998 Aug; 178(2):531-4. PubMed ID: 9697737 [TBL] [Abstract][Full Text] [Related]
15. Cytomegalovirus after heart transplantation: definitions for the guidance of antiviral therapy. Iberer F; Tscheliessnigg K; Halwachs G; Auer T; Wasler A; Petutschnigg B; Schreier G; Müller H; Allmayer T; Prenner G Scand J Infect Dis Suppl; 1995; 99():100-3. PubMed ID: 8668929 [TBL] [Abstract][Full Text] [Related]
16. Editorial commentary: Use of valganciclovir for prevention and treatment of cytomegalovirus disease. Snydman DR Clin Infect Dis; 2008 Jan; 46(1):28-9. PubMed ID: 18171209 [No Abstract] [Full Text] [Related]
17. [Cytomegalovirus effects in solid organ transplantation and the role of antiviral prophylaxis]. Weclawiak H; Mengelle C; Ould Mohamed A; Izopet J; Rostaing L; Kamar N Nephrol Ther; 2010 Nov; 6(6):505-12. PubMed ID: 20829141 [TBL] [Abstract][Full Text] [Related]